1. Home
  2. JELD vs QTRX Comparison

JELD vs QTRX Comparison

Compare JELD & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JELD-WEN Holding Inc.

JELD

JELD-WEN Holding Inc.

HOLD

Current Price

$1.47

Market Cap

138.7M

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$2.49

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JELD
QTRX
Founded
1960
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Forest Products
Biotechnology: Laboratory Analytical Instruments
Sector
Basic Materials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
138.7M
160.0M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
JELD
QTRX
Price
$1.47
$2.49
Analyst Decision
Hold
Hold
Analyst Count
6
2
Target Price
$3.43
$6.00
AVG Volume (30 Days)
1.7M
1.4M
Earning Date
05-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,211,181,000.00
$37,632,000.00
Revenue This Year
N/A
$25.49
Revenue Next Year
$2.06
$10.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
64.52
52 Week Low
$0.93
$2.40
52 Week High
$6.98
$8.77

Technical Indicators

Market Signals
Indicator
JELD
QTRX
Relative Strength Index (RSI) 49.52 28.93
Support Level $1.25 N/A
Resistance Level $2.06 $3.74
Average True Range (ATR) 0.15 0.29
MACD -0.02 -0.02
Stochastic Oscillator 38.39 6.69

Price Performance

Historical Comparison
JELD
QTRX

About JELD JELD-WEN Holding Inc.

JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: